NYSE:ABBVBiotechs
Assessing AbbVie (ABBV)’s Valuation After a Recent Pullback and Strong One-Year Share Price Performance
AbbVie (ABBV) has quietly pulled back about 4% over the past month even as its one year return sits near 35%, setting up an interesting entry check for long term healthcare investors.
See our latest analysis for AbbVie.
The recent 1 month share price return of negative 4.5 percent looks more like a breather than a trend change, given AbbVie still boasts a 1 year total shareholder return near 35 percent and a strong multi year track record.
If you are weighing AbbVie against other...